Prudential plc’s iShares Genomics Immunology and Healthcare ETF IDNA Stock Holding History

Prudential plc’s Portfolio IDNA Stock Details IDNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$468K	Buy	16,100 +1,400	+10%	+$40.6K	﹤0.01%	587
2025 Q4	$385K	Sell	14,700 -5,300	-27%	-$136K	﹤0.01%	634
2025 Q3	$472K	Buy	+20,000	New	+$442K	﹤0.01%	616
2024 Q3	–	Sell	-9,400	Closed	-$218K	–	812
2024 Q2	$218K	Sell	9,400 -16,600	-64%	-$389K	﹤0.01%	720
2024 Q1	$626K	Buy	26,000 +3,500	+16%	+$82K	﹤0.01%	572
2023 Q4	$524K	Sell	22,500 -10,600	-32%	-$213K	0.01%	768
2023 Q3	$674K	Buy	33,100 +4,100	+14%	+$92K	0.01%	658
2023 Q2	$674K	Hold	29,000	–	–	0.01%	701
2023 Q1	$665K	Buy	+29,000	New	+$726K	0.01%	690

Other funds holding IDNA

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

WBG

Wharton Business Group Malvern, Pennsylvania $2.65B AUM 20.73% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

PGA

Portland Global Advisors Portland, Maine $938M AUM 13.22% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Raymond James Financial St Petersburg, Florida $324B AUM 22.36% 1-Year Est. Return

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

CCA

Clearwater Capital Advisors Hoffman Estates, Illinois $1.24B AUM 15.23% 1-Year Est. Return

Prudential plc's IDNA Position: Q1 2026 in Review

Prudential plc increased its iShares Genomics Immunology and Healthcare ETF (IDNA) stake by 9.5% in Q1 2026, buying an estimated $40.6K and bringing the position to 16,100 shares worth $468K. The position accounts for ﹤0.01% of the portfolio, ranked #587.

Prudential plc first reported a position in IDNA in Q1 2023 and has held it in 9 quarters since. The position peaked at $674K in Q2 2023. 60 funds tracked by Wall St. Rank hold IDNA as of Q1 2026.

Prudential plc held 16,100 shares of iShares Genomics Immunology and Healthcare ETF worth $468K as of Q1 2026.
Prudential plc bought 1,400 iShares Genomics Immunology and Healthcare ETF shares in Q1 2026, an estimated $40.6K.
iShares Genomics Immunology and Healthcare ETF made up ﹤0.01% of Prudential plc's portfolio in Q1 2026, its #587 holding.
Prudential plc first reported a position in iShares Genomics Immunology and Healthcare ETF in Q1 2023 and has held it in 9 quarters since.
Prudential plc's iShares Genomics Immunology and Healthcare ETF position peaked at $674K in Q2 2023.
60 funds tracked by Wall St. Rank held iShares Genomics Immunology and Healthcare ETF as of Q1 2026.

Based on Prudential plc's 13F filing for Q1 2026, filed 14 May 2026.